Literature DB >> 18415153

[Pain therapy with implanted medication pumps for chronic pain.].

U Dell1, D Covic, E Singer, M Fendrich.   

Abstract

Epidural or intrathecal opiate analgesia, combined with bupivacain by means of an implanted pump, represents a possibility for providing good pain management for cancer patients as well as other chronic pain patients. Several indications, for implantation of a percutanously refillable pump are demonstrated in 27 patients. Twenty-four patients were treated with epidural and 3 with intrathecal catheters. Nineteen patients were suffering from chronic pain, and 8 had pain because of cancer. Four patients with chronic pain have been treated with continuous epidural opiate analgesia by means of an implanted pump for more than 2 years and 1 patient for more than 5 years. In the course of 2 years there has been no significant increase in the daily dose of buprenorphin given epidurally to patients with chronic pain. There were no addiction problems with opiates given epidurally or intrathecally by means of implanted pumps. Because of a 13% complication rate, pumps and epidural or intrathecal catheters should only be implanted by an experienced team.

Entities:  

Year:  1991        PMID: 18415153     DOI: 10.1007/BF02529661

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  12 in total

1.  [Not Available].

Authors:  W Keup
Journal:  Schmerz       Date:  1988-09       Impact factor: 1.107

2.  [Continuous intrathecal opiate therapy with a portable drug pump in cancer pain].

Authors:  J Motsch; W Bleser; A J Ismaily; L Distler
Journal:  Anasth Intensivther Notfallmed       Date:  1988-10

3.  Epidural versus intrathecal morphine-bupivacaine: assessment of consecutive treatments in advanced cancer pain.

Authors:  P Nitescu; L Appelgren; L E Linder; M Sjöberg; E Hultman; I Curelaru
Journal:  J Pain Symptom Manage       Date:  1990-02       Impact factor: 3.612

4.  [The pharmacokinetics of continuous peridural morphine infusion].

Authors:  H Müller; H Gips; W Krumholz; J Zierski; V Lüben; G Hempelmann
Journal:  Anaesthesist       Date:  1986-11       Impact factor: 1.041

5.  Selection of implantable narcotic delivery systems.

Authors:  S D Waldman; D W Coombs
Journal:  Anesth Analg       Date:  1989-03       Impact factor: 5.108

6.  Long-term pain relief produced by intrathecal morphine infusion in 53 patients.

Authors:  B M Onofrio; T L Yaksh
Journal:  J Neurosurg       Date:  1990-02       Impact factor: 5.115

Review 7.  Use of infusion devices for epidural or intrathecal administration of spinal opioids.

Authors:  J W Kwan
Journal:  Am J Hosp Pharm       Date:  1990-08

8.  Constant infusion of morphine for intractable cancer pain using an implanted pump.

Authors:  S J Hassenbusch; P K Pillay; M Magdinec; K Currie; J W Bay; E C Covington; M Z Tomaszewski
Journal:  J Neurosurg       Date:  1990-09       Impact factor: 5.115

9.  [Morphologic and histologic changes caused by continuous peridural analgesia in a cancer patient].

Authors:  E Ehring; A Boekstegers
Journal:  Reg Anaesth       Date:  1986-04

10.  A preliminary study of long-term epidural morphine for cancer pain via a subcutaneously implanted reservoir.

Authors:  E Liew; Y L Hui
Journal:  Ma Zui Xue Za Zhi       Date:  1989-03
View more
  1 in total

1.  [Pumps and ports for analgesic therapy.].

Authors:  H Müller
Journal:  Schmerz       Date:  1992-09       Impact factor: 1.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.